These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 30979812

  • 1. Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K2P18.1) Background Potassium Channel.
    Lengyel M, Erdélyi F, Pergel E, Bálint-Polonka Á, Dobolyi A, Bozsaki P, Dux M, Király K, Hegedűs T, Czirják G, Mátyus P, Enyedi P.
    Mol Pharmacol; 2019 Jun; 95(6):652-660. PubMed ID: 30979812
    [Abstract] [Full Text] [Related]

  • 2. Selective and state-dependent activation of TRESK (K2P 18.1) background potassium channel by cloxyquin.
    Lengyel M, Dobolyi A, Czirják G, Enyedi P.
    Br J Pharmacol; 2017 Jul; 174(13):2102-2113. PubMed ID: 28419410
    [Abstract] [Full Text] [Related]

  • 3. TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones.
    Dobler T, Springauf A, Tovornik S, Weber M, Schmitt A, Sedlmeier R, Wischmeyer E, Döring F.
    J Physiol; 2007 Dec 15; 585(Pt 3):867-79. PubMed ID: 17962323
    [Abstract] [Full Text] [Related]

  • 4. TRESK and TREK-2 two-pore-domain potassium channel subunits form functional heterodimers in primary somatosensory neurons.
    Lengyel M, Czirják G, Jacobson DA, Enyedi P.
    J Biol Chem; 2020 Aug 28; 295(35):12408-12425. PubMed ID: 32641496
    [Abstract] [Full Text] [Related]

  • 5. TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons.
    Kang D, Kim D.
    Am J Physiol Cell Physiol; 2006 Jul 28; 291(1):C138-46. PubMed ID: 16495368
    [Abstract] [Full Text] [Related]

  • 6. Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK.
    Wright PD, Weir G, Cartland J, Tickle D, Kettleborough C, Cader MZ, Jerman J.
    Biochem Biophys Res Commun; 2013 Nov 15; 441(2):463-8. PubMed ID: 24383077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nonmigraine-associated TRESK K+ channel variant C110R does not increase the excitability of trigeminal ganglion neurons.
    Guo Z, Liu P, Ren F, Cao YQ.
    J Neurophysiol; 2014 Aug 01; 112(3):568-79. PubMed ID: 24805079
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. TRESK (K2P18.1) Background Potassium Channel Is Activated by Novel-Type Protein Kinase C via Dephosphorylation.
    Pergel E, Lengyel M, Enyedi P, Czirják G.
    Mol Pharmacol; 2019 Jun 01; 95(6):661-672. PubMed ID: 30992311
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lamotrigine inhibits TRESK regulated by G-protein coupled receptor agonists.
    Kang D, Kim GT, Kim EJ, La JH, Lee JS, Lee ES, Park JY, Hong SG, Han J.
    Biochem Biophys Res Commun; 2008 Mar 14; 367(3):609-15. PubMed ID: 18190784
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.